September 30, 2026 · Phase 2 readout
TLSA Phase 2 readout: a positive outcome, +6.2%
On September 30, 2026, Tiziana Life Sciences Ltd reached its Phase 2 readout. The result was a positive outcome, and the stock moved +6.2% in the window around the event. It had already run -21.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$0.97
1d before
$1.03
Event day
$1.03
1d after
$0.99
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.3% expected); the stock actually moved +6.2%. Model confidence at the time: 100%.
See the full scored track recordPre-catalyst setup
-21.1%
30-day run-up
9729%
30-day volatility
0.1×
volume spike